Analyses of LMNA-Negative Juvenile Progeroid Cases Confirms Biallelic
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
New ZMPSTE24 (FACE1) Mutations in Patients Affected with Restrictive
New ZMPSTE24 (FACE1) mutations in patients affected with restrictive dermopathy or related progeroid syndromes and mutation update Claire Navarro, Patrice Roll, Vera Esteves-Vieira, Sebastien Courrier, Amandine Boyer, Thuy Duong Nguyen, Le Thi Thanh Huong, Peter Meinke, Winnie Schröder, Valérie Cormier-Daire, et al. To cite this version: Claire Navarro, Patrice Roll, Vera Esteves-Vieira, Sebastien Courrier, Amandine Boyer, et al.. New ZMPSTE24 (FACE1) mutations in patients affected with restrictive dermopathy or related progeroid syndromes and mutation update. European Journal of Human Genetics, Nature Publishing Group, 2013, 22 (8), pp.1002-1011. 10.1038/ejhg.2013.258. hal-01664301 HAL Id: hal-01664301 https://hal-amu.archives-ouvertes.fr/hal-01664301 Submitted on 20 Dec 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. New ZMPSTE24 (FACE1) mutations in patients affected with restrictive dermopathy or related progeroid syndromes and mutation update Claire Laure Navarro*,1,2, Vera Esteves-Vieira3,Se´bastien Courrier1,2, Amandine Boyer3, Thuy Duong -
Genes in Eyecare Geneseyedoc 3 W.M
Genes in Eyecare geneseyedoc 3 W.M. Lyle and T.D. Williams 15 Mar 04 This information has been gathered from several sources; however, the principal source is V. A. McKusick’s Mendelian Inheritance in Man on CD-ROM. Baltimore, Johns Hopkins University Press, 1998. Other sources include McKusick’s, Mendelian Inheritance in Man. Catalogs of Human Genes and Genetic Disorders. Baltimore. Johns Hopkins University Press 1998 (12th edition). http://www.ncbi.nlm.nih.gov/Omim See also S.P.Daiger, L.S. Sullivan, and B.J.F. Rossiter Ret Net http://www.sph.uth.tmc.edu/Retnet disease.htm/. Also E.I. Traboulsi’s, Genetic Diseases of the Eye, New York, Oxford University Press, 1998. And Genetics in Primary Eyecare and Clinical Medicine by M.R. Seashore and R.S.Wappner, Appleton and Lange 1996. M. Ridley’s book Genome published in 2000 by Perennial provides additional information. Ridley estimates that we have 60,000 to 80,000 genes. See also R.M. Henig’s book The Monk in the Garden: The Lost and Found Genius of Gregor Mendel, published by Houghton Mifflin in 2001 which tells about the Father of Genetics. The 3rd edition of F. H. Roy’s book Ocular Syndromes and Systemic Diseases published by Lippincott Williams & Wilkins in 2002 facilitates differential diagnosis. Additional information is provided in D. Pavan-Langston’s Manual of Ocular Diagnosis and Therapy (5th edition) published by Lippincott Williams & Wilkins in 2002. M.A. Foote wrote Basic Human Genetics for Medical Writers in the AMWA Journal 2002;17:7-17. A compilation such as this might suggest that one gene = one disease. -
LMNA-Related Disorders
LMNA-Related Disorders Indications for Ordering Genetics To confirm a clinical diagnosis of a LMNA-related disorder, Genes: LMNA such as: • Hutchinson-Gilford progeria syndrome (HGPS) Inheritance: See table • Emery-Dreifuss muscular dystrophy type 2 (EDMD2) Penetrance: Varies by syndrome • Limb-Girdle muscular dystrophy 1B (LGMD1B) • Charcot-Marie-Tooth 2B1 (CMT2B1) Structure/Function • Familial partial lipodystrophy, Dunnigan type (FPLD) • Composed of 12 exons • LMNA-related dilated cardiomyopathy (DCM) • LMNA encodes isoforms A and C of the lamin protein • Mandibulo-acral dysplasia (MAD) o Structural component of the nuclear membrane • Atypical Werner syndrome (WS) o Anchors heterochromatin to the inner nuclear • Restrictive dermopathy (RD) membrane • Other, intermediate phenotypes Variants Test Description • Alternative splicing of the LMNA gene produces two proteins (lamin A and C) Polymerase chain reaction (PCR) followed by bidirectional • Variants occur throughout the gene sequencing of all coding regions and intron/exon o Predominantly missense boundaries of the LMNA gene o p.G608G variant in exon 11 . Present in all individuals with HGPS Tests to Consider Test Interpretation Primary Tests LMNA-Related Disorders (LMNA) Sequencing 2004543 Sensitivity/Specificity • Confirm suspected laminopathy caused by LMNA variants, • Clinical sensitivity: dependent on the specific LMNA- including HGPS, EDMD2, LGMD1B, CMT2B1, FPLD , DCM, related disorder MAD, WS, or RD • Analytic sensitivity/specificity: 99% Related Test Results Familial Mutation, -
Early Onset Diabetes in Two Children Due to Progeria, a Monogenic Disease of DNA Repair
CASE REPORT DO I: 10.4274/jcrpe.galenos.2019.2019.0126 J Clin Res Pediatr Endocrinol 2020;12(3):315-318 Early Onset Diabetes in Two Children due to Progeria, a Monogenic Disease of DNA Repair Martin Holder¹, Valerie Schwitzgebel² ¹Klinikum Stuttgart, Olgahospital, Department of Pediatric Endocrinology and Diabetology, Stuttgart, Germany ²Hopital des Enfants, Endocrinologie et Diabetologie Pediatriques, Geneve, Switzerland What is already known on this topic? Less is known about type 2 like diabetes mellitus in children and adolescents with progeria-syndrome although they have a high risk of developing diabetes mellitus. What this study adds? Early and regular screening for diabetes mellitus are mandatory. Treatment with metformin at an early stage should be recommended to prevent early symptoms of diabetes and potentially delay the clinical course of progeria Abstract Progeria syndrome is a rare disorder in childhood which causes accelerated systemic aging. Due to the accelerated aging process, disorders which normally occur only in old age will appear in these children at a much younger age. We report two children with progeria syndrome, in whom fulminant diabetes mellitus manifested at a very early age. Keywords: Progeria syndrome, diabetes mellitus, metformin, prevention. Introduction cardiovascular disease can occur. Additionally, they may have audiologic, dental, and ophthalmologic issues Progeria syndrome is a group of very rare genetic disorders that impair their lives. Less is known about metabolic which are characterized by premature aging and classified complications in children with progeria syndrome. In by various names based on causative etiology: Hutchinson- WS, also known as adult progeroid syndrome, type 2 like Gilford progeria syndrome (HGPS), Néstor-Guillermo progeria diabetes mellitus is one of the clinical manifestations of syndrome, atypical progeria syndromes, restrictive dermopathy, the disease and attention must give to the differential mandibuloacral dysplasia, Werner syndrome (WS), Bloom diagnosis (1). -
Werner and Hutchinson–Gilford Progeria Syndromes: Mechanistic Basis of Human Progeroid Diseases
REVIEWS MECHANISMS OF DISEASE Werner and Hutchinson–Gilford progeria syndromes: mechanistic basis of human progeroid diseases Brian A. Kudlow*¶, Brian K. Kennedy* and Raymond J. Monnat Jr‡§ Abstract | Progeroid syndromes have been the focus of intense research in part because they might provide a window into the pathology of normal ageing. Werner syndrome and Hutchinson–Gilford progeria syndrome are two of the best characterized human progeroid diseases. Mutated genes that are associated with these syndromes have been identified, mouse models of disease have been developed, and molecular studies have implicated decreased cell proliferation and altered DNA-damage responses as common causal mechanisms in the pathogenesis of both diseases. Progeroid syndromes are heritable human disorders with therefore termed segmental, as opposed to global, features that suggest premature ageing1. These syndromes progeroid syndromes. Among the segmental progeroid have been well characterized as clinical disease entities, syndromes, the syndromes that most closely recapitu- and in many instances the associated genes and causative late the features of human ageing are Werner syndrome mutations have been identified. The identification of (WS), Hutchinson–Gilford progeria syndrome (HGPS), genes that are associated with premature-ageing-like Cockayne syndrome, ataxia-telangiectasia, and the con- syndromes has increased our understanding of molecu- stitutional chromosomal disorders of Down, Klinefelter lar pathways that protect cell viability and function, and -
Early ACCESS Diagnosed Conditions List
Iowa Early ACCESS Diagnosed Conditions Eligibility List List adapted with permission from Early Intervention Colorado To search for a specific word type "Ctrl F" to use the "Find" function. Is this diagnosis automatically eligible for Early Medical Diagnosis Name Other Names for the Diagnosis and Additional Diagnosis Information ACCESS? 6q terminal deletion syndrome Yes Achondrogenesis I Parenti-Fraccaro Yes Achondrogenesis II Langer-Saldino Yes Schinzel Acrocallosal syndrome; ACLS; ACS; Hallux duplication, postaxial polydactyly, and absence of the corpus Acrocallosal syndrome, Schinzel Type callosum Yes Acrodysplasia; Arkless-Graham syndrome; Maroteaux-Malamut syndrome; Nasal hypoplasia-peripheral dysostosis-intellectual disability syndrome; Peripheral dysostosis-nasal hypoplasia-intellectual disability (PNM) Acrodysostosis syndrome Yes ALD; AMN; X-ALD; Addison disease and cerebral sclerosis; Adrenomyeloneuropathy; Siemerling-creutzfeldt disease; Bronze schilder disease; Schilder disease; Melanodermic Leukodystrophy; sudanophilic leukodystrophy; Adrenoleukodystrophy Pelizaeus-Merzbacher disease Yes Agenesis of Corpus Callosum Absence of the corpus callosum; Hypogenesis of the corpus callosum; Dysplastic corpus callosum Yes Agenesis of Corpus Callosum and Chorioretinal Abnormality; Agenesis of Corpus Callosum With Chorioretinitis Abnormality; Agenesis of Corpus Callosum With Infantile Spasms And Ocular Anomalies; Chorioretinal Anomalies Aicardi syndrome with Agenesis Yes Alexander Disease Yes Allan Herndon syndrome Allan-Herndon-Dudley -
Hutchinson-Gilford Progeria Syndrome—Current Status and Prospects for Gene Therapy Treatment
cells Review Hutchinson-Gilford Progeria Syndrome—Current Status and Prospects for Gene Therapy Treatment Katarzyna Piekarowicz † , Magdalena Machowska † , Volha Dzianisava and Ryszard Rzepecki * Laboratory of Nuclear Proteins, Faculty of Biotechnology, University of Wroclaw, Fryderyka Joliot-Curie 14a, 50-383 Wroclaw, Poland; [email protected] (K.P.); [email protected] (M.M.); [email protected] (V.D.) * Correspondence: [email protected]; Tel.: +48-71-3756308 † Joint first author. Received: 1 December 2018; Accepted: 19 January 2019; Published: 25 January 2019 Abstract: Hutchinson-Gilford progeria syndrome (HGPS) is one of the most severe disorders among laminopathies—a heterogeneous group of genetic diseases with a molecular background based on mutations in the LMNA gene and genes coding for interacting proteins. HGPS is characterized by the presence of aging-associated symptoms, including lack of subcutaneous fat, alopecia, swollen veins, growth retardation, age spots, joint contractures, osteoporosis, cardiovascular pathology, and death due to heart attacks and strokes in childhood. LMNA codes for two major, alternatively spliced transcripts, give rise to lamin A and lamin C proteins. Mutations in the LMNA gene alone, depending on the nature and location, may result in the expression of abnormal protein or loss of protein expression and cause at least 11 disease phenotypes, differing in severity and affected tissue. LMNA gene-related HGPS is caused by a single mutation in the LMNA gene in exon 11. The mutation c.1824C > T results in activation of the cryptic donor splice site, which leads to the synthesis of progerin protein lacking 50 amino acids. -
Outcomes of 4 Years of Molecular Genetic Diagnosis on a Panel Of
Grelet et al. Orphanet Journal of Rare Diseases (2019) 14:288 https://doi.org/10.1186/s13023-019-1189-z RESEARCH Open Access Outcomes of 4 years of molecular genetic diagnosis on a panel of genes involved in premature aging syndromes, including laminopathies and related disorders Maude Grelet1,2, Véronique Blanck1, Sabine Sigaudy1,2, Nicole Philip1,2, Fabienne Giuliano3, Khaoula Khachnaoui3, Godelieve Morel4,5, Sarah Grotto6, Julia Sophie7, Céline Poirsier8, James Lespinasse9, Laurent Alric10, Patrick Calvas7, Gihane Chalhoub11, Valérie Layet12, Arnaud Molin13, Cindy Colson13, Luisa Marsili14, Patrick Edery4,5, Nicolas Lévy1,2,15 and Annachiara De Sandre-Giovannoli1,2,15* Abstract Background: Segmental progeroid syndromes are a heterogeneous group of rare and often severe genetic disorders that have been studied since the twentieth century. These progeroid syndromes are defined as segmental because only some of the features observed during natural aging are accelerated. Methods: Since 2015, the Molecular Genetics Laboratory in Marseille La Timone Hospital proposes molecular diagnosis of premature aging syndromes including laminopathies and related disorders upon NGS sequencing of a panel of 82 genes involved in these syndromes. We analyzed the results obtained in 4 years on 66 patients issued from France and abroad. Results: Globally, pathogenic or likely pathogenic variants (ACMG class 5 or 4) were identified in about 1/4 of the cases; among these, 9 pathogenic variants were novel. On the other hand, the diagnostic yield of our panel was over 60% when the patients were addressed upon a nosologically specific clinical suspicion, excepted for connective tissue disorders, for which clinical diagnosis may be more challenging. -
Download CGT Exome V2.0
CGT Exome version 2. -
Étude Rétrospective Portant Sur 4 Ans De Diagnostic Moléculaire Dans Le Cadre De Syndromes D’Origine Génétique Avec Vieillissement Prématuré Maude Grelet
Étude rétrospective portant sur 4 ans de diagnostic moléculaire dans le cadre de syndromes d’origine génétique avec vieillissement prématuré Maude Grelet To cite this version: Maude Grelet. Étude rétrospective portant sur 4 ans de diagnostic moléculaire dans le cadre de syn- dromes d’origine génétique avec vieillissement prématuré. Sciences du Vivant [q-bio]. 2019. dumas- 02359875 HAL Id: dumas-02359875 https://dumas.ccsd.cnrs.fr/dumas-02359875 Submitted on 12 Nov 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Etude rétrospective portant sur 4 ans de diagnostic moléculaire dans le cadre de syndromes d'origine génétique avec vieillissement prématuré T H È S E A R T I C L E Présentée et publiquement soutenue devant LA FACULTÉ DES SCIENCES MEDICALES ET PARAMEDICALES DE MARSEILLE Le 7 Juin 2019 Par Madame Maude GRELET Née le 3 janvier 1989 à Angers (49) Pour obtenir le grade de Docteur en Médecine D.E.S. de GÉNÉTIQUE MÉDICALE, CLINIQUE, CHROMOSOMIQUE ET MOLÉCULAIRE Membres du Jury de la Thèse : Monsieur le Professeur LEVY Nicolas Président Madame -
Lamin A/C Mechanotransduction in Laminopathies
cells Review Lamin A/C Mechanotransduction in Laminopathies , Francesca Donnaloja , Federica Carnevali, Emanuela Jacchetti * y and Manuela Teresa Raimondi y Department of Chemistry, Materials and Chemical Engineering “G.Natta”, Politecnico di Milano, 20133 Milano, Italy; [email protected] (F.D.); [email protected] (F.C.); [email protected] (M.T.R.) * Correspondence: [email protected] These authors contributed equally. y Received: 30 March 2020; Accepted: 22 May 2020; Published: 24 May 2020 Abstract: Mechanotransduction translates forces into biological responses and regulates cell functionalities. It is implicated in several diseases, including laminopathies which are pathologies associated with mutations in lamins and lamin-associated proteins. These pathologies affect muscle, adipose, bone, nerve, and skin cells and range from muscular dystrophies to accelerated aging. Although the exact mechanisms governing laminopathies and gene expression are still not clear, a strong correlation has been found between cell functionality and nuclear behavior. New theories base on the direct effect of external force on the genome, which is indeed sensitive to the force transduced by the nuclear lamina. Nuclear lamina performs two essential functions in mechanotransduction pathway modulating the nuclear stiffness and governing the chromatin remodeling. Indeed, A-type lamin mutation and deregulation has been found to affect the nuclear response, altering several downstream cellular processes such as mitosis, chromatin organization, DNA replication-transcription, and nuclear structural integrity. In this review, we summarize the recent findings on the molecular composition and architecture of the nuclear lamina, its role in healthy cells and disease regulation. We focus on A-type lamins since this protein family is the most involved in mechanotransduction and laminopathies. -
Blueprint Genetics Progeria and Progeroid Syndromes Panel
Progeria and Progeroid Syndromes Panel Test code: DE0201 Is a 17 gene panel that includes assessment of non-coding variants. Is ideal for patients with a clinical suspicion of Hutchinson-Gilford progeria syndrome or a syndrome with progeroid features. About Progeria and Progeroid Syndromes Hutchinson-Gilford progeria syndrome (HGPS) is caused by LMNA mutations with autosomal dominant inheritance but almost all individuals with HGPS have a de novo mutation. All the major syndromes with proreroid features have autosomal recessive inheritance although the ALDH18A1 related cutis laxa is also inherited in dominant manner. HGPS manifest with features of accelerated aging observed in early childhood. Age of disease onset and progress rate varies but is remarkably consistent overall. Children with HGPS usually appear normal at birth. Profound failure to thrive occurs during the first year. Patients have a head disproportionately large for face, prominent eyes, partial alopecia progressing to total alopecia, loss of subcutaneous fat, progressive joint contractures, bone changes and nail dystrophy occur by age of three. Later symptoms include conductive hearing loss, dental crowding and partial lack of secondary tooth eruption. Motor and mental development is normal. Average life span is approximately 15 years. Premature death occurs as a result of atherosclerotic events, either myocardial infarct or stroke. Diagnosis is based on clinical features and detection of heterozygous LMNA variants either within exon 11 (termed classic HGPS) or at the intronic border of exon 11 (termed atypical HGPS). Although no other gene than LMNA associates with HGPS, premature aging occur in many other syndromes with so-called progeroid features, thus the panel also include genes causing the following syndromes: Cockayne syndrome, congenital generalized lipodystrophy, cutis laxa and progeroid type Ehlers-Danlos syndrome among some others.